You need to know exactly how to reconstitute the powder, calculate your dose, prepare the injection site, and administer GHK-Cu safely and effectively
Animal studies on BPC-157 have demonstrated a favorable safety profile, with no established LD50 (lethal dose) and no documented organ toxicity, carcinogenicity, or mutagenicity at tested doses
Sikiric, P., Seiwerth, S., Rucman, R., Drmic, D., Stupnisek, M., Kokot, A.,
Sharing methodology details, including exact spray counts and timing, alongside any published or internal results makes it far easier for other researchers to attempt replication, which remains a valuable step for any topical peptide protocol
Reliable storage practices protect valuable peptides like BPC-157 and TB-500.
How BPC-157 Fits into a Broader Peptide Treatment Plan BPC-157 is rarely prescribed in isolation